Enhancing CNS Repair in neurological disease: Challenges arising from neurodegeneration and rewiring of the network

CNS Drugs

Volumn 25, Issue 7, 2011, Pages 555-573

  Xu, Xiaohua ^a   Warrington, Arthur E ^a   Bieber, Allan J ^a   Rodriguez, Moses ^a  

^a MAYO CLINIC   (United States)

Author keywords

Alzheimers disease; Cerebral ischaemia; Monoclonal antibodies; Multiple sclerosis; Neurodegenerative disorders; Parkinsons disease; Spinal cord injuries; Stem cell therapies

Indexed keywords

IMMUNOGLOBULIN M; MYELIN ASSOCIATED GLYCOPROTEIN; RECOMBINANT HUMAN IMMUNOGLOBULIN M 22; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTIFICIAL NEURAL NETWORK; ASTROCYTOSIS; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CELL LOSS; CENTRAL NERVOUS SYSTEM; EMBRYONIC STEM CELL; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; LIPID RAFT; MYELINATION; NERVE DEGENERATION; NERVE FIBER GROWTH; NEURAL STEM CELL; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SPINAL CORD INJURY; STEM CELL TRANSPLANTATION;

ANIMALS; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; NERVE NET; NERVE REGENERATION; NEURODEGENERATIVE DISEASES; STEM CELL TRANSPLANTATION;

EID: 79959547494     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.2165/11587830-000000000-00000     Document Type: Review

References (123)

1. Hagg T, Oudega M. Degenerative and spontaneous regenerative processes after spinal cord injury. J Neurotrauma 2006 Mar-Apr; 23 (3-4): 264-80 (Pubitemid 43726309)
2. Silver J, Miller JH. Regeneration beyond the glial scar. Nat Rev Neurosci 2004 Feb; 5 (2): 146-56 (Pubitemid 38160289)
3. Lo EH. A new penumbra: transitioning from injury into repair after stroke. Nat Med 2008 May; 14 (5): 497-500 (Pubitemid 351655209)
4. LaFerla FM, Green KN, Oddo S. Intracellular amyloidbeta in Alzheimers disease. Nat Rev Neurosci 2007 Jul; 8 (7): 499-509
5. Daniela F, Vescovi AL, Bottai D. The stem cells as a potential treatment for neurodegeneration. Methods Mol Biol 2007; 399: 199-213
6. Leker RR, Lasri V, Chernoguz D. Growth factors improve neurogenesis and outcome after focal cerebral ischemia. J Neural Transm 2009 Nov; 116 (11): 1397-402
7. Sahni V, Kessler JA. Stem cell therapies for spinal cord injury. Nat Rev Neurol 2010 Jul; 6 (7): 363-72
8. McDonald JW, Liu XZ, Qu Y, et al. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med 1999 Dec; 5 (12): 1410-2
9. Erdo F, Buhrle C, Blunk J, et al. Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. J Cereb Blood Flow Metab 2003 Jul; 23 (7): 780-5 (Pubitemid 36818686)
10. Bjorklund LM, Sanchez-Pernaute R, Chung S, et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A 2002 Feb 19; 99 (4): 2344-9 (Pubitemid 34169063)
11. Lee SH, Lumelsky N, Studer L, et al. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 2000 Jun; 18 (6): 675-9 (Pubitemid 30415305)
12. Eriksson PS, Perfilieva E, Bjork-Eriksson T, et al. Neurogenesis in the adult human hippocampus.Nat Med 1998 Nov; 4 (11): 1313-7 (Pubitemid 28512114)
13. Toda H, Takahashi J, Iwakami N, et al. Grafting neural stem cells improved the impaired spatial recognition in ischemic rats. Neurosci Lett 2001 Dec 4; 316 (1): 9-12 (Pubitemid 33092021)
14. Shim JW, Park CH, Bae YC, et al. Generation of functional dopamine neurons from neural precursor cells isolated from the subventricular zone and white matter of the adult rat brain using Nurr1 overexpression. Stem Cells 2007 May; 25 (5): 1252-62
15. Bonner JF, Blesch A, Neuhuber B, et al. Promoting directional axon growth from neural progenitors grafted into the injured spinal cord. J Neurosci Res May 1; 88 (6): 1182-92
16. Chen J, Li Y, Wang L, et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001 Apr; 32 (4): 1005-11 (Pubitemid 32285175)
17. Newman MB, Davis CD, Kuzmin-Nichols N, et al. Human umbilical cord blood (HUCB) cells for central nervous system repair. Neurotox Res 2003; 5 (5): 355-68
18. Sykova E, Homola A, Mazanec R, et al. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant 2006; 15 (8-9): 675-87 (Pubitemid 46095251)
19. Munoz-Elias G, Marcus AJ, Coyne TM, et al. Adult bone marrow stromal cells in the embryonic brain: engraftment, migration, differentiation, and long-term survival. J Neurosci 2004 May 12; 24 (19): 4585-95 (Pubitemid 38656614)
20. Pluchino S, Zanotti L, Rossi B, et al. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 2005 Jul 14; 436 (7048): 266-71 (Pubitemid 41021278)
21. Martino G, Pluchino S. The therapeutic potential of neural stem cells. Nat Rev Neurosci 2006 May; 7 (5): 395-406
22. Ming GL, Song H. Adult neurogenesis in the mammalian central nervous system. Annu Rev Neurosci 2005; 28: 223-50 (Pubitemid 41098905)
23. Arvidsson A, Collin T, Kirik D, et al. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 2002 Sep; 8 (9): 963-70 (Pubitemid 35033700)
24. Hamilton LK, Truong MK, Bednarczyk MR, et al. Cellular organization of the central canal ependymal zone, a niche of latent neural stem cells in the adult mammalian spinal cord. Neuroscience 2009 Dec 15; 164 (3): 1044-56
25. Bath KG, Lee FS. Neurotrophic factor control of adult SVZ neurogenesis. Dev Neurobiol 2010 Apr; 70 (5): 339-49
26. Case LC, Tessier-Lavigne M. Regeneration of the adult central nervous system. Curr Biol 2005 Sep 20; 15 (18): R749-53
27. Bredesen DE, Rao RV, Mehlen P. Cell death in the nervous system. Nature 2006 Oct 19; 443 (7113): 796-802 (Pubitemid 44622684)
28. Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005 Aug 15; 202 (4): 473-7 (Pubitemid 41186945)
29. Frank-Cannon TC, Alto LT, McAlpine FE, et al. Does neuroinflammation fan the flame in neurodegenerative diseases? Mol Neurodegener 2009; 4: 47
30. Ballatore C, Lee VM, Trojanowski JQ. Tau-mediated neurodegeneration in Alzheimers disease and related disorders. Nat Rev Neurosci 2007 Sep; 8 (9): 663-72 (Pubitemid 47283144)
31. Auluck PK, Caraveo G, Lindquist S. a-Synuclein: membrane interactions and toxicity in Parkinsons disease. Annu Rev Cell Dev Biol 2010 Nov 10; (26): 211-33
32. Ilieva H, Polymenidou M, Cleveland DW. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol 2009 Dec 14; 187 (6): 761-72
33. Glass CK, Saijo K, Winner B, et al. Mechanisms underlying inflammation in neurodegeneration. Cell 2010 Mar 19; 140 (6): 918-34
34. Wyss-Coray T, Loike JD, Brionne TC, et al. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat Med 2003 Apr; 9 (4): 453-7 (Pubitemid 36460080)
35. Tan L, Gordon KB, Mueller JP, et al. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes. J Immunol 1998 May 1; 160 (9): 4271-9 (Pubitemid 28217282)
36. Constantinescu CS, Tani M, Ransohoff RM, et al. Astrocytes as antigen-presenting cells: expression of IL-12/ IL-23. J Neurochem 2005 Oct; 95 (2): 331-40 (Pubitemid 41457502)
37. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998 Jan 29; 338 (5): 278-85 (Pubitemid 28065253)
38. Rodriguez M, Scheithauer B. Ultrastructure of multiple sclerosis. Ultrastruct Pathol 1994 Jan-Apr; 18 (1-2): 3-13 (Pubitemid 24131605)
39. Minghetti L. Role of inflammation in neurodegenerative diseases. Curr Opin Neurol 2005 Jun; 18 (3): 315-21 (Pubitemid 40813762)
40. Fugger L, Friese MA, Bell JI. From genes to function: the next challenge to understanding multiple sclerosis. Nat Rev Immunol 2009 Jun; 9 (6): 408-17
41. Beleza-Meireles A, Al-Chalabi A. Genetic studies of amyotrophic lateral sclerosis: controversies and perspectives. Amyotroph Lateral Scler 2009 Feb; 10 (1): 1-14
42. Lesage S, Brice A. Parkinsons disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet 2009 Apr 15; 18 (R1): R48-59
43. Ertekin-Taner N. Genetics of Alzheimer disease in the preand post-GWAS era. Alzheimers Res Ther 2010; 2 (1): 3
44. Goate AM, Haynes AR, Owen MJ, et al. Predisposing locus for Alzheimers disease on chromosome 21. Lancet 1989 Feb 18; 1 (8634): 352-5 (Pubitemid 19103075)
45. Goate A, Chartier-Harlin MC, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimers disease. Nature 1991 Feb 21; 349 (6311): 704-6 (Pubitemid 21912142)
46. Sherrington R, Rogaev EI, LiangY, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimers disease. Nature 1995 Jun 29; 375 (6534): 754-60
47. Levy-Lahad E, Wijsman EM, Nemens E, et al. A familial Alzheimers disease locus on chromosome 1. Science 1995 Aug 18; 269 (5226): 970-3
48. Rogaev EI, Sherrington R, Rogaeva EA, et al. Familial Alzheimers disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimers disease type 3 gene. Nature 1995 Aug 31; 376 (6543): 775-8
49. Bertram L, Tanzi RE. Genome-wide association studies in Alzheimers disease.Hum Mol Genet 2009 Oct 15; 18 (R2): R137-45
50. Borchelt DR, Thinakaran G, Eckman CB, et al. Familial Alzheimers disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo.Neuron 1996Nov; 17 (5): 1005-13 (Pubitemid 26424026)
51. Xia W, Zhang J, Kholodenko D, et al. Enhanced production and oligomerization of the 42-residue amyloid betaprotein by Chinese hamster ovary cells stably expressing mutant presenilins. J Biol Chem 1997 Mar 21; 272 (12): 7977-82 (Pubitemid 27137361)
52. Holtzman DM, Bales KR, Tenkova T, et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimers disease. Proc Natl Acad Sci U S A 2000 Mar 14; 97 (6): 2892-7 (Pubitemid 30159268)
53. Baulac S, LaVoie MJ, Kimberly WT, et al. Functional gamma-secretase complex assembly in Golgi/trans-Golgi network: interactions among presenilin, nicastrin, Aph1, Pen-2, and gamma-secretase substrates. Neurobiol Dis 2003 Nov; 14 (2): 194-204 (Pubitemid 37311284)
54. Dion PA, Daoud H, Rouleau GA. Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Nat Rev Genet 2009 Nov; 10 (11): 769-82
55. Tam SJ, Watts RJ. Connecting vascular and nervous system development: angiogenesis and the blood-brain barrier. Annu Rev Neurosci 2010; 33: 379-408
56. Begley DJ, Brightman MW. Structural and functional aspects of the blood-brain barrier. Prog Drug Res 2003; 61: 39-78 (Pubitemid 37187402)
57. Zlokovic BV, Apuzzo ML. Strategies to circumvent vascular barriers of the CNS. Neurosurgery 1998; 43 (4): 877-8 (Pubitemid 28436339)
58. Schlageter KE, Molnar P, Lapin GD, et al. Microvessel organization and structure in experimental brain tumors: microvessel populations with distinctive structural and functional properties.MicrovascRes 1999Nov; 58 (3): 312-28 (Pubitemid 29531878)
59. Banerjee S, Bhat MA. Neuron-glial interactions in bloodbrain barrier formation. Annu Rev Neurosci 2007; 30: 235-58 (Pubitemid 47218757)
60. Abbott NJ, Ronnback L, Hansson E. Astrocyteendothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006 Jan; 7 (1): 41-53
61. Rouach N, Glowinski J, Giaume C. Activity-dependent neuronal control of gap-junctional communication in astrocytes. J Cell Biol 2000 Jun 26; 149 (7): 1513-26 (Pubitemid 30437623)
62. Rouach N, Koulakoff A, Abudara V, et al. Astroglial metabolic networks sustain hippocampal synaptic transmission. Science 2008 Dec 5; 322 (5907): 1551-5
63. Bushong EA, Martone ME, Jones YZ, et al. Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J Neurosci 2002 Jan 1; 22 (1): 183-92 (Pubitemid 34033496)
64. Khuth ST, Strazielle N, Giraudon P, et al. Impairment of blood-cerebrospinal fluid barrier properties by retrovirusactivated T lymphocytes: reduction in cerebrospinal fluidto- blood efflux of prostaglandin E2. J Neurochem 2005 Sep; 94 (6): 1580-93 (Pubitemid 41324640)
65. Navikas V, LinkH.Review: cytokines and the pathogenesis of multiple sclerosis. JNeurosciRes 1996 Aug 15; 45 (4): 322-33
66. Nave KA, Trapp BD. Axon-glial signaling and the glial support of axon function. Annu Rev Neurosci 2008; 31: 535-61
67. Rakic P, Ayoub AE, Breunig JJ, et al. Decision by division: making cortical maps. Trends Neurosci 2009 May; 32 (5): 291-301
68. Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol 2010 Jan; 119 (1): 7-35
69. Baumann N, Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 2001 Apr; 81 (2): 871-927 (Pubitemid 32267079)
70. Black JA, Waxman SG. The perinodal astrocyte. Glia 1988; 1 (3): 169-83
71. Ransohoff RM, Perry VH. Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 2009; 27: 119-45
72. Lindvall O, Kokaia Z. Prospects of stem cell therapy for replacing dopamine neurons in Parkinsons disease. Trends Pharmacol Sci 2009 May; 30 (5): 260-7
73. Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 2009 Dec; 32 (12): 638-47
74. Margolis RK, Margolis RU. Nervous tissue proteoglycans. EXS 1994; 70: 145-77
75. Yamagata T, Saito H, Habuchi O, et al. Purification and properties of bacterial chondroitinases and chondrosulfatases. J Biol Chem 1968 Apr 10; 243 (7): 1523-35
76. Bradbury EJ, Carter LM. Manipulating the glial scar: chondroitinase ABC as a therapy for spinal cord injury. Brain Res Bull 2010 Mar 84 4-5 306-16
77. Brambilla R, Persaud T, Hu X, et al. Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation. J Immunol 2009 Mar 1; 182 (5): 2628-40
78. Hamby ME, Hewett JA,Hewett SJ. TGF-beta1 potentiates astrocytic nitric oxide production by expanding the population of astrocytes that express NOS-2. Glia 2006 Nov 1; 54 (6): 566-77
79. Takano T, Kang J, Jaiswal JK, et al. Receptor-mediated glutamate release from volume sensitive channels in astrocytes. Proc Natl Acad Sci U S A 2005 Nov 8; 102 (45): 16466-71 (Pubitemid 41688937)
80. Rolls A, Shechter R, Schwartz M. The bright side of the glial scar inCNSrepair. NatRev Neurosci 2009Mar; 10 (3): 235-41
81. Trendelenburg G, Dirnagl U. Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning. Glia 2005 Jun; 50 (4): 307-20 (Pubitemid 40780837)
82. Kuhlmann T, Lassmann H, Bruck W. Diagnosis of inflammatory demyelination in biopsy specimens: a practical approach. Acta Neuropathol 2008 Mar; 115 (3): 275-87
83. Voskuhl RR, Peterson RS, Song B, et al. Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J Neurosci 2009 Sep 16; 29 (37): 11511-22
84. Thal DR, Schultz C, Dehghani F, et al. Amyloid betaprotein (Abeta)-containing astrocytes are located preferentially near N-terminal-truncated Abeta deposits in the human entorhinal cortex. Acta Neuropathol 2000 Dec; 100 (6): 608-17
85. Faulkner JR, Herrmann JE, Woo MJ, et al. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 2004 Mar 3; 24 (9): 2143-55 (Pubitemid 38314546)
86. Li L, Lundkvist A, Andersson D, et al. Protective role of reactive astrocytes in brain ischemia. J Cereb Blood Flow Metab 2008 Mar; 28 (3): 468-81 (Pubitemid 351304260)
87. Di Giorgio FP, Carrasco MA, Siao MC, et al. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci 2007 May; 10 (5): 608-14 (Pubitemid 46652442)
88. Nagai M, Re DB, Nagata T, et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 2007 May; 10 (5): 615-22 (Pubitemid 46652435)
89. McKerracher L, David S, Jackson DL, et al. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron 1994 Oct; 13 (4): 805-11
90. Mukhopadhyay G, Doherty P, Walsh FS, et al. A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron 1994 Sep; 13 (3): 757-67 (Pubitemid 24300179)
91. Chen MS, Huber AB, van der Haar ME, et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000 Jan 27; 403 (6768): 434-9 (Pubitemid 30073093)
92. GrandPre T, Nakamura F, Vartanian T, et al. Identification of the Nogo inhibitor of axon regeneration as a reticulon protein. Nature 2000 Jan 27; 403 (6768): 439-44 (Pubitemid 30073094)
93. Prinjha R, Moore SE, Vinson M, et al. Inhibitor of neurite outgrowth in humans. Nature 2000 Jan 27; 403 (6768): 383-4 (Pubitemid 30073077)
94. Wang KC, Koprivica V, Kim JA, et al. Oligodendrocytemyelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 2002 Jun 27; 417 (6892): 941-4 (Pubitemid 34716869)
95. Filbin MT. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev Neurosci 2003 Sep; 4 (9): 703-13 (Pubitemid 37280150)
96. Yiu G, He Z. Glial inhibition of CNS axon regeneration. Nat Rev Neurosci 2006 Aug; 7 (8): 617-27 (Pubitemid 44106744)
97. Mi S, Sandrock A, Miller RH. LINGO-1 and its role in CNS repair. Int J Biochem Cell Biol 2008; 40 (10): 1971-8
98. Cao Z, Gao Y, Deng K, et al. Receptors for myelin inhibitors: structures and therapeutic opportunities. Mol Cell Neurosci 2010 Jan; 43 (1): 1-14
99. Yang LJ, Zeller CB, Shaper NL, et al. Gangliosides are neuronal ligands for myelin-associated glycoprotein. Proc Natl Acad Sci U S A 1996 Jan 23; 93 (2): 814-8 (Pubitemid 26041175)
100. Vyas AA, Patel HV, Fromholt SE, et al. Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration. Proc Natl Acad Sci U S A 2002 Jun 11; 99 (12): 8412-7 (Pubitemid 34651066)
101. Atwal JK, Pinkston-Gosse J, Syken J, et al. PirB is a functional receptor for myelin inhibitors of axonal regeneration. Science 2008 Nov 7; 322 (5903): 967-70
102. Goh EL, Young JK, Kuwako K, et al. Beta1-integrin mediates myelin-associated glycoprotein signaling in neuronal growth cones. Mol Brain 2008; 1 (1): 10
103. Quarles RH. Myelin-associated glycoprotein (MAG): past, present and beyond. JNeurochem2007Mar; 100 (6): 1431-48 (Pubitemid 46376206)
104. Schnaar RL, Lopez PH. Myelin-associated glycoprotein and its axonal receptors. J Neurosci Res 2009 Nov 15; 87 (15): 3267-76
105. Bartsch U, Bandtlow CE, Schnell L, et al. Lack of evidence that myelin-associated glycoprotein is a major inhibitor of axonal regeneration in the CNS. Neuron 1995 Dec; 15 (6): 1375-81 (Pubitemid 26005374)
106. Lee JK, Geoffroy CG, Chan AF, et al. Assessing spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deficient mice. Neuron 2010 Jun 10; 66 (5): 663-70
107. Yin X, Crawford TO, Griffin JW, et al. Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J Neurosci 1998 Mar 15; 18 (6): 1953-62 (Pubitemid 28141401)
108. Nguyen T, Mehta NR, Conant K, et al. Axonal protective effects of the myelin-associated glycoprotein. J Neurosci 2009 Jan 21; 29 (3): 630-7
109. Warrington AE, Bieber AJ, Van Keulen V, et al. Neuronbinding human monoclonal antibodies support central nervous system neurite extension. J Neuropathol Exp Neurol 2004 May; 63 (5): 461-73 (Pubitemid 38669667)
110. Schnell L, Schwab ME. Axonal regeneration in the rat spinal cord produced by an antibody against myelinassociated neurite growth inhibitors. Nature 1990 Jan 18; 343 (6255): 269-72 (Pubitemid 20030644)
111. Brosamle C, Huber AB, Fiedler M, et al. Regeneration of lesioned corticospinal tract fibers in the adult rat induced by a recombinant, humanized IN-1 antibody fragment. J Neurosci 2000 Nov 1; 20 (21): 8061-8
112. Rodriguez M, Lennon VA, Benveniste EN, et al. Remyelination by oligodendrocytes stimulated by antiserum to spinal cord. J Neuropathol Exp Neurol 1987 Jan; 46 (1): 84-95 (Pubitemid 17232257)
113. Howe CL, Bieber AJ,Warrington AE, et al. Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody. Neurobiol Dis 2004 Feb; 15 (1): 120-31 (Pubitemid 38134387)
114. Miller DJ, Sanborn KS, Katzmann JA, et al. Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis. J Neurosci 1994 Oct; 14 (10): 6230-8 (Pubitemid 24307813)
115. Warrington AE, Asakura K, Bieber AJ, et al. Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc Natl Acad Sci U S A 2000 Jun 6; 97 (12): 6820-5 (Pubitemid 30412798)
116. Rodriguez M, Warrington AE, Pease LR. Invited article: human natural autoantibodies in the treatment of neurologic disease. Neurology 2009 Apr 7; 72 (14): 1269-76
117. Casali P, Schettino EW. Structure and function of natural antibodies. Curr Top Microbiol Immunol 1996; 210: 167-79 (Pubitemid 26024271)
118. Boes M. Role of natural and immune IgM antibodies in immune responses. Mol Immunol 2000 Dec; 37 (18): 1141-9
119. Elkon K, Casali P. Nature and functions of autoantibodies. Nat Clin Pract Rheumatol 2008 Sep; 4 (9): 491-8
120. Binder CJ. Natural IgM antibodies against oxidationspecific epitopes. J Clin Immunol 2010 May; 30 Suppl. 1: S56-60
121. Jeannin P, Jaillon S, Delneste Y. Pattern recognition receptors in the immune response against dying cells. Curr Opin Immunol 2008 Oct; 20 (5): 530-7
122. Vollmers HP, Brandlein S. Natural antibodies and cancer. J Autoimmun 2007 Dec; 29 (4): 295-302 (Pubitemid 47633144)
123. Watzlawik J, Holicky E, Edberg DD, et al. Human remyelination promoting antibody inhibits apoptotic signaling and differentiation through Lyn kinase in primary rat oligodendrocytes. Glia 2010 Nov 15; 58 (15): 1782-93